StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · REVB·Healthcare

Revelation Biosciences, Inc. Stock Analysis & AI Score

Revelation Biosciences, Inc. (REVB) has an ST Score of 36.6 (C), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy.

Market Closed
$0.87
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
37
ST Score
36.6/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

REVB
36.6out of 100
Grade C

Revelation Biosciences, Inc. (REVB) has an ST Score of 36.6 (C), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy.

Strongest
GrowthA+
Weakest
ProfitabilityF
All factor grades
  • GrowthA+
  • ValuationC+
  • Financial StrengthC
  • MomentumD+
  • ProfitabilityF
  • Piotroski2/9
Score methodology
Press Releases

Contact

REVB stock: frequently asked questions

What is REVB's ST Score?

Revelation Biosciences, Inc. (REVB) has an ST Score of 36.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is REVB a buy, hold, or sell?

Analysts rate REVB a Buy. Our ST Score grades it C (36.6/100). The ST Score is a data-driven signal, not a recommendation.

What are REVB's factor grades?

Valuation C+, Profitability F, Financial Strength C, Momentum D+, Growth A+.

What is REVB's valuation grade?

Revelation Biosciences, Inc. (REVB) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is REVB's growth grade?

Revelation Biosciences, Inc. (REVB) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is REVB's profitability grade?

Revelation Biosciences, Inc. (REVB) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is REVB's financial strength grade?

Revelation Biosciences, Inc. (REVB) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is REVB's Piotroski score?

Revelation Biosciences, Inc. (REVB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.